0001579600-18-000002.txt : 20180312 0001579600-18-000002.hdr.sgml : 20180312 20180312104235 ACCESSION NUMBER: 0001579600-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180312 DATE AS OF CHANGE: 20180312 EFFECTIVENESS DATE: 20180312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T3D Therapeutics, Inc. CENTRAL INDEX KEY: 0001579600 IRS NUMBER: 461674269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307423 FILM NUMBER: 18682507 BUSINESS ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-949-0517 MAIL ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 D 1 primary_doc.xml X0708 D LIVE 0001579600 T3D Therapeutics, Inc. 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 919-949-0517 DELAWARE None None Corporation true John Didsbury 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Charles Lineberry 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Barry Buzogany 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director John A. Golden 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Tom Mendell 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2018-03-02 false true false 0 18000000 6000000 12000000 false 1 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false T3D Therapeutics, Inc. John Didsbury John Didsbury Preisdent and Chief Executive Officer 2018-03-10